Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Risedronate, R&D Systems™
SDP

Catalog No. 350450
Change view
Click to view available options
Quantity:
50 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
35-045-0 50 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Catalog No. 35-045-0 Supplier R&D Systems Supplier No. 3504/50

Item Discontinued Customers require a valid business account associated to their profile to access pricing and ordering options.

missing translation for 'validMainframeMsg'

This item is not returnable. View return policy

A Tocris product, part of R&D Systems. Farnesyl diphosphate (FPP) synthase inhibitor

Orally active biphosphonate that inhibits farnesyl diphosphate (FPP) synthase (IC50 = 100 nM). Exhibits antiproliferative and proapoptotic activity in numerous tumor cell lines and inhibits osteoclast-mediated bone resorption in vivo.

Chemical Identifiers

CAS 115436-72-1
Molecular Formula C7H10NNaO7P2
Molecular Weight (g/mol) 305.09
MDL Number MFCD00867080,MFCD01706268,MFCD00867080
InChI Key DRFDPXKCEWYIAW-UHFFFAOYNA-M
Synonym risedronate sodium
PubChem CID 131675130
IUPAC Name sodium hydrogen [1-hydroxy-1-phosphono-2-(pyridin-3-yl)ethyl]phosphonate
SMILES [Na+].OC(CC1=CN=CC=C1)(P(O)(O)=O)P(O)([O-])=O

Specifications

Quantity 50 mg
Formula Weight 305.09
Percent Purity >99%
Product Line Tocris
Chemical Name or Material Risedronate
Recommended Storage Store at Room Temperature
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.